GnRH-R antagonist 1 (Compound 21a), is an orally active, membrane-permeable agent with a high binding affinity (IC50=0.57 nM) and potent in vitro antagonistic efficacy (IC50=2.18 nM). It is utilized in research focused on advanced prostate cancer and the prevention of premature LH surges [1].
Molecular Weight:
721.65
CAS Number:
[2826273-90-7]
Formula:
C31H28F5N7O6S
Target:
GNRH Receptor
T72492
* VAT and and shipping costs not included. Errors and price changes excepted
